Michael F Mahoney Boston Scientific Corp (BSX) insider trading activity

Michael F Mahoney is Chairman, President & CEO of BOSTON SCIENTIFIC CORP. Currently has a direct ownership of 1.65 Million shares of BSX, which is worth approximately $168 Million. The most recent transaction as insider was on Feb 17, 2025, when has been sold 8,865 shares (Common Stock) at a price of $106.11 per share, resulting in proceeds of $940,665. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.65M

8.69% 3M change

1.23% 12M change

Total Value Held $168 Million

Michael F Mahoney Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 17 2025	SELL Payment of exercise price or tax liability	$940,665 $106.11 p/Share	8,865 Reduced 0.53%	1,653,354 Common Stock
Feb 17 2025	BUY Exercise of conversion of derivative security	-	18,334 Added 1.09%	1,662,219 Common Stock
Feb 16 2025	SELL Payment of exercise price or tax liability	$834,555 $106.11 p/Share	7,865 Reduced 0.48%	1,643,885 Common Stock
Feb 16 2025	BUY Exercise of conversion of derivative security	-	16,265 Added 0.98%	1,651,750 Common Stock
Feb 14 2025	SELL Payment of exercise price or tax liability	$847,818 $106.11 p/Share	7,990 Reduced 0.49%	1,635,485 Common Stock
Feb 14 2025	BUY Exercise of conversion of derivative security	-	16,524 Added 1.0%	1,643,475 Common Stock
Feb 12 2025	SELL Payment of exercise price or tax liability	$700,832 $105.77 p/Share	6,626 Reduced 0.41%	1,626,951 Common Stock
Feb 12 2025	BUY Exercise of conversion of derivative security	-	13,704 Added 0.83%	1,633,577 Common Stock
Feb 11 2025	SELL Payment of exercise price or tax liability	$6,667,731 $105.98 p/Share	62,915 Reduced 3.74%	1,619,873 Common Stock
Feb 11 2025	BUY Grant, award, or other acquisition	-	130,118 Added 7.18%	1,682,788 Common Stock
Jan 01 2025	SELL Payment of exercise price or tax liability	$2,291,593 $89.32 p/Share	25,656 Reduced 1.63%	1,552,670 Common Stock
Jan 01 2025	BUY Exercise of conversion of derivative security	-	57,121 Added 3.49%	1,578,326 Common Stock
Nov 05 2024	SELL Open market or private sale	$13,827,991 $84.95 p/Share	162,778 Reduced 9.67%	1,521,205 Common Stock
Nov 05 2024	BUY Exercise of conversion of derivative security	$1,878,582 $16.79 p/Share	111,887 Added 6.23%	1,683,983 Common Stock
Oct 07 2024	SELL Open market or private sale	$13,775,817 $84.63 p/Share	162,777 Reduced 9.38%	1,572,096 Common Stock
Oct 07 2024	BUY Exercise of conversion of derivative security	$1,878,565 $16.79 p/Share	111,886 Added 6.06%	1,734,873 Common Stock
Sep 05 2024	SELL Open market or private sale	$13,212,609 $81.17 p/Share	162,777 Reduced 9.12%	1,622,987 Common Stock
Sep 05 2024	BUY Exercise of conversion of derivative security	$1,878,565 $16.79 p/Share	111,886 Added 5.9%	1,785,764 Common Stock
Feb 18 2024	SELL Payment of exercise price or tax liability	$476,076 $65.82 p/Share	7,233 Reduced 0.43%	1,673,878 Common Stock
Feb 18 2024	BUY Exercise of conversion of derivative security	-	16,307 Added 0.96%	1,681,111 Common Stock
Feb 17 2024	SELL Payment of exercise price or tax liability	$535,182 $65.82 p/Share	8,131 Reduced 0.49%	1,664,804 Common Stock
Feb 17 2024	BUY Exercise of conversion of derivative security	-	18,333 Added 1.08%	1,672,935 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$474,825 $65.82 p/Share	7,214 Reduced 0.43%	1,654,602 Common Stock
Feb 16 2024	BUY Exercise of conversion of derivative security	-	16,265 Added 0.97%	1,661,816 Common Stock
Feb 14 2024	SELL Payment of exercise price or tax liability	$483,281 $65.95 p/Share	7,328 Reduced 0.44%	1,645,551 Common Stock

Also insider at

BAX

BAXTER INTERNATIONAL INC Healthcare

Director

CVS

CVS HEALTH Corp Healthcare

Director

MFM